Maraviroc: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2026

10 March 2026

  • curprev 19:2719:27, 10 March 2026‎ Ostermayer talk contribs‎ 5,669 bytes +5,669‎ Created page with "Maraviroc is a CCR5 co-receptor antagonist (entry inhibitor) used in combination with other antiretrovirals for '''CCR5-tropic HIV-1 only'''. It is unique among antiretrovirals in targeting a host cell receptor rather than a viral enzyme. A tropism assay is required before use.<ref name="SelzentryPI">Selzentry (maraviroc) [prescribing information]. Research Triangle Park, NC: ViiV Healthcare; 2020.</ref> ==Administration== *Type: CCR5 co-receptor a..."
Retrieved from "https://www.wikem.org/wiki/Maraviroc"